Cases & Deals

Sanofi challenges Amgen's patent applications for anti-PCSK9 antibodies before Australian Patent Office

Clients Regeneron Pharmaceuticals, Inc.; Sanofi

Jones Day is acting in an opposition proceeding for Sanofi and Regeneron in relation to their challenge to a portfolio of applications held by Amgen Inc. that claim anti-PCSK9 antibodies and their use in the treatment of hypercholesterolemia.